Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal(Georgetown University), Michael J. Peluso(San Francisco General Hospital), Akiko Iwasaki(Yale University), Stephen M. Hewitt(National Institutes of Health), David Putrino(Icahn School of Medicine at Mount Sinai), Mark M. Painter(Translational Therapeutics (United States)), Etheresia Pretorius(University of Liverpool), Lael M. Yonker(The University of Texas Southwestern Medical Center), Daniel S. Chertow(National Institute of Allergy and Infectious Diseases), Johan Van Weyenbergh(Rega Institute for Medical Research), Michael B. VanElzakker(Massachusetts General Hospital), Morgane Bomsel(Centre National de la Recherche Scientifique), Gene S. Tan(J. Craig Venter Institute), Diane E. Griffin(Johns Hopkins University), Yu Qian(J. Craig Venter Institute), Michela Locci(University of Pennsylvania), Soo Aleman(Karolinska University Hospital), Alessio Fasano(Harvard University), Christopher L. Dupont(J. Craig Venter Institute), Saurabh Mehandru(Icahn School of Medicine at Mount Sinai), Sara Cherry(California University of Pennsylvania), Dominique Salmon(Assistance Publique – Hôpitaux de Paris), Marcus Buggert(Karolinska University Hospital), E. John Wherry(Parker Institute for Cancer Immunotherapy), Marcelo Freire(J. Craig Venter Institute), Steven G. Deeks(University of California, San Francisco), Michaela Müller‐Trutwin(Institut Pasteur), E. Wesley Ely(Vanderbilt University), Vincent C. Marconi(Emory University), Linda N. Geng(Palo Alto University), Petter Brodin(Karolinska University Hospital), Nadia R. Roan(Gladstone Institutes), Helen Davies(Cardiff and Vale University Health Board), Harlan M. Krumholz(Yale New Haven Hospital), David A. Price(University Hospital of Wales), Timothy J. Henrich(University of California, San Francisco)
Cited by 50
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
|Circulation|2006|2.1k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k